Ram Palanki, PharmD

Ram Palanki, PharmD is an accomplished results-oriented senior executive and entrepreneur with demonstrated hands-on experience and skills in optimizing people, products and processes to achieve operational and organizational excellence. Dr. Palanki has nearly 20 years of drug development and commercialization experience in the biopharmaceutical industry and has proven success in start-up and turn around environments in both small and large organizations.

Currently, he serves as the Senior Vice President of commercial strategy & operations at REGENXBIO, a leader in AAV gene therapy, and is responsible for the commercialization of their pipeline across the ophthalmology, central nervous system, neuromuscular disease franchises and future portfolio.

He was formerly Senior Vice President of Commercial for Americas at Santen Inc. Prior to Santen, Ram was the Head of Global marketing, sales & commercial operations at ThromboGenics. Over the span of his career, Dr. Palanki has held roles of increasing responsibility at several companies including Neovista, Genentech & Novartis. He actively serves as a strategic advisory board member to multiple biotech, technology start-up companies and non-profits in ophthalmology.

Ram holds a BS and PharmD from Albany College of Pharmacy, Union University, NY, a post doctorate from Rutgers University, NJ.